Add BrightSurf on Google Email

Science News Archive 2004 - Page 22


Page 22 of 135

NIH recognizes IU as leader in STD research

The NIH awarded Indiana University a $7 million grant to establish the Midwest Sexually Transmitted Infections and Topical Microbicides Cooperative Research Center. The center will focus on researching epidemiology, acquisition, prevention, and pathogenesis of sexually transmitted infections in young women.

Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights

A study of 28 individuals with acrophobia found that combining D-cycloserine (DCS) with virtual reality exposure therapy significantly reduced fear of heights, with effects lasting at least three months. The treatment works by facilitating 'fear extinction' in the brain, a process previously used to treat phobias and post-traumatic str...

SourceEmory University Health Sciences Center·JournalArchives of General Psychiatry·DateNov 5, 2004

Occult hepatitis B in dialysis patients

A recent study published in Hepatology found that occult HBV infection is prevalent in adult hemodialysis patients, with a rate four to five times higher than standard HBsAg testing. The majority of infections were associated with low viral loads and the sG145R-mutant.

SourceWiley·JournalHepatology·DateNov 5, 2004

Tiny paddle oscillator senses the mass of a virus

Researchers at Cornell University have created a device that can detect as few as six viruses using a tiny paddle oscillator. The device, which uses the natural resonant frequency of the paddles to sense changes in mass, has the potential to differentiate between various pathogens and toxic organic chemicals.

SourceCornell University·JournalApplied Physics Letters·DateNov 4, 2004

The effect of osteoporosis drugs on osteoarthritis of the knee

A nationwide study found that women taking osteoporosis medications had fewer bone abnormalities and less knee pain associated with osteoarthritis. The research suggests that these medications, primarily alendronate and estrogen, may offer protective benefits for the development of knee OA.

SourceWiley·JournalArthritis & Rheumatism·DateNov 4, 2004

The anti-arthritic effects of bee venom

Researchers found that melittin, a compound in bee venom, blocks the expression of inflammatory genes in synovial cells. This inhibition can lead to reduced tissue swelling and osteophyte formation, suggesting a potential treatment for RA patients.

SourceWiley·JournalArthritis & Rheumatism·DateNov 4, 2004